253 related articles for article (PubMed ID: 23510297)
41. Temperature-dependent drug release from DPPC:C12H25-PNIPAM-COOH liposomes: control of the drug loading/release by modulation of the nanocarriers' components.
Pippa N; Meristoudi A; Pispas S; Demetzos C
Int J Pharm; 2015 May; 485(1-2):374-82. PubMed ID: 25776453
[TBL] [Abstract][Full Text] [Related]
42. Lysolipid incorporation in dipalmitoylphosphatidylcholine bilayer membranes enhances the ion permeability and drug release rates at the membrane phase transition.
Mills JK; Needham D
Biochim Biophys Acta; 2005 Oct; 1716(2):77-96. PubMed ID: 16216216
[TBL] [Abstract][Full Text] [Related]
43. Triggered release of hydrophilic agents from plasmalogen liposomes using visible light or acid.
Anderson VC; Thompson DH
Biochim Biophys Acta; 1992 Aug; 1109(1):33-42. PubMed ID: 1504078
[TBL] [Abstract][Full Text] [Related]
44. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
[TBL] [Abstract][Full Text] [Related]
45. Lipid membrane composition influences drug release from dioleoylphosphatidylethanolamine-based liposomes on exposure to ultrasound.
Evjen TJ; Nilssen EA; Fowler RA; Røgnvaldsson S; Brandl M; Fossheim SL
Int J Pharm; 2011 Mar; 406(1-2):114-6. PubMed ID: 21185927
[TBL] [Abstract][Full Text] [Related]
46. Detection of nanosized ordered domains in DOPC/DPPC and DOPC/Ch binary lipid mixture systems of large unilamellar vesicles using a TEMPO quenching method.
Suga K; Umakoshi H
Langmuir; 2013 Apr; 29(15):4830-8. PubMed ID: 23506052
[TBL] [Abstract][Full Text] [Related]
47. Tumor targeting in vivo by means of thermolabile fusogenic liposomes.
Zellmer S; Cevc G
J Drug Target; 1996; 4(1):19-29. PubMed ID: 8798875
[TBL] [Abstract][Full Text] [Related]
48. Size of thermosensitive liposomes influences content release.
Hossann M; Wang T; Wiggenhorn M; Schmidt R; Zengerle A; Winter G; Eibl H; Peller M; Reiser M; Issels RD; Lindner LH
J Control Release; 2010 Nov; 147(3):436-43. PubMed ID: 20727921
[TBL] [Abstract][Full Text] [Related]
49. Characterizing the freezing behavior of liposomes as a tool to understand the cryopreservation procedures.
Siow LF; Rades T; Lim MH
Cryobiology; 2007 Dec; 55(3):210-21. PubMed ID: 17905224
[TBL] [Abstract][Full Text] [Related]
50. Comparative Experimental and Computational Study of Monoalkyl Chain Phosphatidylcholine-Containing Thermoresponsive Liposomes.
Eleftheriou K; Sideratou Z; Thanassoulas A; Papakyriakou A; Tsiourvas D
J Phys Chem B; 2016 Jun; 120(24):5417-28. PubMed ID: 27280363
[TBL] [Abstract][Full Text] [Related]
51. Interaction of doxorubicin and dipalmitoylphosphatidylcholine liposomes.
Mady MM; Shafaa MW; Abbase ER; Fahium AH
Cell Biochem Biophys; 2012 Apr; 62(3):481-6. PubMed ID: 22194155
[TBL] [Abstract][Full Text] [Related]
52. Reconsideration of drug release from temperature-sensitive liposomes.
Ono A; Takeuchi K; Sukenari A; Suzuki T; Adachi I; Ueno M
Biol Pharm Bull; 2002 Jan; 25(1):97-101. PubMed ID: 11824566
[TBL] [Abstract][Full Text] [Related]
53. Acid-catalyzed plasmenylcholine hydrolysis and its effect on bilayer permeability: a quantitative study.
Gerasimov OV; Schwan A; Thompson DH
Biochim Biophys Acta; 1997 Mar; 1324(2):200-14. PubMed ID: 9092707
[TBL] [Abstract][Full Text] [Related]
54. Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.
Boakye CH; Patel K; Singh M
Int J Pharm; 2015 Jul; 489(1-2):106-16. PubMed ID: 25910414
[TBL] [Abstract][Full Text] [Related]
55. Solubilization of negatively charged DPPC/DPPG liposomes by bile salts.
Hildebrand A; Beyer K; Neubert R; Garidel P; Blume A
J Colloid Interface Sci; 2004 Nov; 279(2):559-71. PubMed ID: 15464825
[TBL] [Abstract][Full Text] [Related]
56. Interaction between amphipathic triblock copolymers and L-α-dipalmitoyl phosphatidylcholine large unilamellar vesicles.
Palominos MA; Vilches D; Bossel E; Soto-Arriaza MA
Colloids Surf B Biointerfaces; 2016 Dec; 148():30-40. PubMed ID: 27591568
[TBL] [Abstract][Full Text] [Related]
57. Curcumin disorders 1,2-dipalmitoyl-sn-glycero-3-phosphocholine membranes and favors the formation of nonlamellar structures by 1,2-dielaidoyl-sn-glycero-3-phosphoethanolamine.
Pérez-Lara A; Ausili A; Aranda FJ; de Godos A; Torrecillas A; Corbalán-García S; Gómez-Fernández JC
J Phys Chem B; 2010 Aug; 114(30):9778-86. PubMed ID: 20666521
[TBL] [Abstract][Full Text] [Related]
58. Effects of poly(ethylene glycol) (PEG) chain length of PEG-lipid on the permeability of liposomal bilayer membranes.
Hashizaki K; Taguchi H; Itoh C; Sakai H; Abe M; Saito Y; Ogawa N
Chem Pharm Bull (Tokyo); 2003 Jul; 51(7):815-20. PubMed ID: 12843588
[TBL] [Abstract][Full Text] [Related]
59. Effects of alcohol-induced lipid interdigitation on proton permeability in L-alpha-dipalmitoylphosphatidylcholine vesicles.
Zeng J; Smith KE; Chong PL
Biophys J; 1993 Oct; 65(4):1404-14. PubMed ID: 8274634
[TBL] [Abstract][Full Text] [Related]
60. Controlling spatial distribution of functional lipids in a supported lipid bilayer prepared from vesicles.
Lee HS; Kim YC; Wang Z; Brenner JS; Muzykantov VR; Myerson JW; Composto RJ
J Colloid Interface Sci; 2024 Jun; 664():1042-1055. PubMed ID: 38522178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
